Arthroplasty, Replacement, Shoulder Clinical Trial
Official title:
Clinical and Radiographic Outcomes of Reverse Shoulder Arthroplasty Performed With 36-mm CoCrMo vs 40-mm Cross-linked UHMWPE Glenospheres.
Study Design: Single arm, retrospective and prospective, single center, post-market clinical study Purpose:To demonstrate the safety and effectiveness of the SMR Reverse HP Shoulder System device for primary, fracture or revision total shoulder replacement out to 24 months. The eligible study population is the entire population that underwent a reverse shoulder arthroplasty performed with 36-mm CoCrMo versus 40-mm cross-linked UHMWPE glenospheres between January 1, 2013 and January 1, 2020 at Wrightington Hospital (UK) in accordance with the indication for use of the product.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04507412 -
Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty
|
Phase 4 | |
| Recruiting |
NCT06025331 -
Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
|
N/A | |
| Active, not recruiting |
NCT04861714 -
Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)
|
N/A | |
| Recruiting |
NCT05030220 -
Testosterone Levels and Cutibacterium
|
||
| Enrolling by invitation |
NCT03806881 -
Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant
|
||
| Recruiting |
NCT04258267 -
Which Factors Influence the Outcome After Anatomical and Reverse Shoulder Arthroplasty?
|
N/A | |
| Completed |
NCT03790267 -
Functional Outcomes and Quality of Life in Hip, Knee and Shoulder Arthroplasty
|